Catalyst Wire Dossier Catalyst Wire Dossier

bupivacaine 0.75%

bupivacaine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bupivacaine 0.75%, covering 2022-05-27 to 2022-05-27. Get the full timeline:

Most recent: Clinical Trial Update: ED90 of 0.75% Bupivacaine for Bilateral Tubal Ligation (BTL) [Phase 4]

See pricing